RecruitingNCT01607502

Database for Clinical and Anamnestic Data in Pulmonary Hypertension


Sponsor

Medical University of Graz

Enrollment

900 participants

Start Date

Jul 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg measured in the right heart catheterization. There are different forms of PH defined in the classification of Dana Point 2008. PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like the echocardiography, stress echocardiography and cardio pulmonary exercise testing. In the diagnosis process and in the follow up of PH patients biomarkers like NTproBNP are helpful. There are no specific biomarkers for the disease which can make the diagnosis process easier and predict prognosis. The systematic data collection in a data base provides better information about patients in daily routine and clinical studies as well as in the design of new studies.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • patients with pulmonary hypertension
  • patients at risk for getting pulmonary hypertension
  • patients who have symptoms which my be due to pulmonary hypertension when we have their written informed consent.

Exclusion Criteria1

  • patients without written informed consent

Locations(1)

Medical University of Graz

Graz, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01607502


Related Trials